News
- RESEARCHES2024.03.19
- Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing
- RESEARCHES2024.02.22
- Registration of iPS cell stock (QHJI strain) for clinical use as a U.S. Drug Master File
- RESEARCHES2024.01.18
- CiRA_F and CIRM Sign Agreement for Widespread Use of iPS Cell Stock
- RESEARCHES2023.12.26
- Start of Investigator-Initiated Clinical Study of iPS Cell-Derived Dopaminergic Progenitor Cells for Parkinson's Disease in the United States
- RESEARCHES2023.06.14
- Provision of HLA Genome-edited iPS Cell Stock for Clinical Use
- RESEARCHES2023.04.11
- CiRA Foundation Signed Letter of Intent with Transformative Cell Processing Company
- RESEARCHES2023.04.05
- Provision of a New iPS Cell Line for Clinical Use
- RESEARCHES2023.03.02
- Knowledge Palette and CiRA Foundation Executed a Collaborative Research Contract to Evaluate and Improve Quality of iPS Cells